ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO to present at Emerging Growth Conference
|
|
Vivo
|
14 |
3.7K |
1 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
14
|
3.7K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO Steven Lydeamore presentation to Sharewise
|
|
Vivo
|
24 |
5.6K |
1 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
24
|
5.6K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron Travelan record sales globally, Australia and USA
|
|
Vivo
|
23 |
7.1K |
5 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
23
|
7.1K
|
5
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron Travelan record sales globally, Australia and USA
|
|
Vivo
|
23 |
7.1K |
4 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
23
|
7.1K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO Steven Lydeamore presentation to Sharewise
|
|
Vivo
|
24 |
5.6K |
1 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
24
|
5.6K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO Steven Lydeamore presentation to Sharewise
|
|
Vivo
|
24 |
5.6K |
4 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
24
|
5.6K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO Steven Lydeamore presentation to Sharewise
|
|
Vivo
|
24 |
5.6K |
4 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
24
|
5.6K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Vivo
|
214 |
65K |
3 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
214
|
65K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Vivo
|
214 |
65K |
2 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
214
|
65K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Vivo
|
214 |
65K |
2 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
214
|
65K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Vivo
|
214 |
65K |
1 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
214
|
65K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Vivo
|
214 |
65K |
1 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
214
|
65K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Vivo
|
214 |
65K |
0 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
214
|
65K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Vivo
|
214 |
65K |
0 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
214
|
65K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Vivo
|
214 |
65K |
6 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
214
|
65K
|
6
|
|
ASX - By Stock
|
IMC |
Re:
Ann: IMM-529 pre-IND FDA filing
|
|
Vivo
|
16 |
3.4K |
0 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
16
|
3.4K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: IMM-529 pre-IND FDA filing
|
|
Vivo
|
16 |
3.4K |
1 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
16
|
3.4K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Credit Given Where Due, However.
|
|
Vivo
|
31 |
6.7K |
2 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
31
|
6.7K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Credit Given Where Due, However.
|
|
Vivo
|
31 |
6.7K |
2 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
31
|
6.7K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.8K |
1.2M |
6 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Webcast slides for new Efti clinical data in 1st line HNSCC
|
|
Vivo
|
100 |
57K |
5 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
100
|
57K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Webcast slides for new Efti clinical data in 1st line HNSCC
|
|
Vivo
|
100 |
57K |
4 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
100
|
57K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
$100 million capital raising done and dusted
|
|
Vivo
|
27 |
14K |
8 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
27
|
14K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Immutep
|
|
Vivo
|
10 |
5.3K |
5 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
10
|
5.3K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep completes institutional pro-rata offer & placement
|
|
Vivo
|
44 |
18K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
44
|
18K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep completes institutional pro-rata offer & placement
|
|
Vivo
|
44 |
18K |
2 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
44
|
18K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Banter and General Comments
|
|
Vivo
|
74 |
25K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
74
|
25K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Board Changes
|
|
Vivo
|
11 |
3.2K |
3 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
11
|
3.2K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Banter and General Comments
|
|
Vivo
|
74 |
25K |
2 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
74
|
25K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Board Change
|
|
Vivo
|
3 |
1.6K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
3
|
1.6K
|
0
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX invited to present at international lymphoma forum
|
|
Vivo
|
25 |
13K |
1 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
25
|
13K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX invited to present at international lymphoma forum
|
|
Vivo
|
25 |
13K |
0 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
25
|
13K
|
0
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX invited to present at international lymphoma forum
|
|
Vivo
|
25 |
13K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
25
|
13K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
Vivo
|
995 |
354K |
13 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
995
|
354K
|
13
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
Vivo
|
995 |
354K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
995
|
354K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
Vivo
|
73 |
25K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
73
|
25K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Marc do your job!
|
|
Vivo
|
42 |
20K |
4 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
42
|
20K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Marc do your job!
|
|
Vivo
|
42 |
20K |
9 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
42
|
20K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
Vivo
|
573 |
237K |
9 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
573
|
237K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
Vivo
|
573 |
237K |
21 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
573
|
237K
|
21
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
Vivo
|
995 |
354K |
8 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
995
|
354K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
Vivo
|
995 |
354K |
5 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
995
|
354K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
Vivo
|
995 |
354K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
995
|
354K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
Vivo
|
995 |
354K |
3 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
995
|
354K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
Vivo
|
483 |
175K |
9 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
483
|
175K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity launches $121 million equity raise
|
|
Vivo
|
90 |
39K |
11 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
90
|
39K
|
11
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity launches $121 million equity raise
|
|
Vivo
|
90 |
39K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
90
|
39K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity launches $121 million equity raise
|
|
Vivo
|
90 |
39K |
7 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
90
|
39K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Trading Halt
|
|
Vivo
|
13 |
6.7K |
8 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
13
|
6.7K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
Vivo
|
995 |
354K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
995
|
354K
|
0
|
|